Author: ivst_admin

NovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World Congress

By ivst_adminIn NovAccess Global Press ReleasesPosted July 8, 2021

NovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDA

By ivst_adminIn NovAccess Global Press ReleasesPosted June 28, 2021

NovAccess Global Readies for Development of Novel Immunotherapies for Brain Tumor Patients with pre-IND meeting scheduled with the FDA and Files Form 10-K for Fiscal 2020 and Form 10-Q for FQ1/FQ2, 2021

By ivst_adminIn NovAccess Global Press Releases, Press ReleasePosted June 8, 2021

NovAccess Global Secures Worldwide Rights to Approved Patent

By ivst_adminIn NovAccess Global Press ReleasesPosted November 18, 2020

NovAccess Global Enhances Scientific Advisory Board with Distinguished Industry Experts and adds Chief Financial Officer

By ivst_adminIn NovAccess Global Press ReleasesPosted October 21, 2020

NovAccess Global Appoints Dwain Irvin, Ph.D., MPH as New Chief Executive Officer

By ivst_adminIn NovAccess Global Press ReleasesPosted October 15, 2020

NovAccess Global Acquires StemVax Therapeutics from Innovest Global

By ivst_adminIn NovAccess Global Press ReleasesPosted September 9, 2020

XsunX, Inc. Changes Name to NovAccess Global Inc.

By ivst_adminIn NovAccess Global Press ReleasesPosted August 26, 2020

XsunX, Inc. Changes Name to NovAccess Global Inc.

By ivst_adminIn UncategorizedPosted August 26, 2020

Innovest Global Announces Upcoming Conference Participation and Biotech Award

By ivst_adminIn NovAccess Global Press ReleasesPosted September 4, 2019